• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IgG3 和 IgM 被鉴定为恢复期血浆池中 SARS-CoV-2 中和的关键。

IgG3 and IgM Identified as Key to SARS-CoV-2 Neutralization in Convalescent Plasma Pools.

机构信息

Research & Development, CSL Behring Innovation GmbH, Marburg, Germany.

Research & Development, CSL Behring, Bern, Switzerland.

出版信息

PLoS One. 2022 Jan 4;17(1):e0262162. doi: 10.1371/journal.pone.0262162. eCollection 2022.

DOI:10.1371/journal.pone.0262162
PMID:34982806
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8726489/
Abstract

Analysis of convalescent plasma derived from individuals has shown that IgG3 has the most important role in binding to SARS-CoV-2 antigens; however, this has not yet been confirmed in large studies, and the link between binding and neutralization has not been confirmed. By analyzing plasma pools consisting of 247-567 individual convalescent donors, we demonstrated the binding of IgG3 and IgM to Spike-1 protein and the receptor-binding domain correlates strongly with viral neutralization in vitro. Furthermore, despite accounting for only approximately 12% of total immunoglobulin mass, collectively IgG3 and IgM account for approximately 80% of the total neutralization. This may have important implications for the development of potent therapies for COVID-19, as it indicates that hyperimmune globulins or convalescent plasma donations with high IgG3 concentrations may be a highly efficacious therapy.

摘要

对个体恢复期血浆的分析表明,IgG3 在与 SARS-CoV-2 抗原结合方面起着最重要的作用;然而,这尚未在大规模研究中得到证实,结合与中和之间的联系也尚未得到证实。通过分析由 247-567 名个体恢复期供体组成的血浆池,我们证明了 IgG3 和 IgM 与 Spike-1 蛋白的结合以及受体结合域与体外病毒中和强烈相关。此外,尽管 IgG3 和 IgM 仅占总免疫球蛋白质量的约 12%,但其总和却约占总中和作用的 80%。这对于开发 COVID-19 的有效疗法可能具有重要意义,因为这表明高 IgG3 浓度的超免疫球蛋白或恢复期血浆捐献可能是一种非常有效的疗法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f36/8726489/4d04a95dadb2/pone.0262162.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f36/8726489/c70bdd3e0671/pone.0262162.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f36/8726489/908f2387a6f4/pone.0262162.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f36/8726489/dac5816bc751/pone.0262162.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f36/8726489/4d04a95dadb2/pone.0262162.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f36/8726489/c70bdd3e0671/pone.0262162.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f36/8726489/908f2387a6f4/pone.0262162.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f36/8726489/dac5816bc751/pone.0262162.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f36/8726489/4d04a95dadb2/pone.0262162.g004.jpg

相似文献

1
IgG3 and IgM Identified as Key to SARS-CoV-2 Neutralization in Convalescent Plasma Pools.IgG3 和 IgM 被鉴定为恢复期血浆池中 SARS-CoV-2 中和的关键。
PLoS One. 2022 Jan 4;17(1):e0262162. doi: 10.1371/journal.pone.0262162. eCollection 2022.
2
Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples.比较分析来自人类血清样本的 SARS-CoV-2 结合抗体(IgG、IgM、IgA)和中和抗体。
J Immunol Methods. 2021 Feb;489:112937. doi: 10.1016/j.jim.2020.112937. Epub 2020 Nov 28.
3
Neutralizing Antibody Responses to SARS-CoV-2 in Recovered COVID-19 Patients Are Variable and Correlate With Disease Severity and Receptor-Binding Domain Recognition.恢复期 COVID-19 患者对 SARS-CoV-2 的中和抗体反应具有变异性,与疾病严重程度和受体结合域识别相关。
Front Immunol. 2022 Jan 31;13:830710. doi: 10.3389/fimmu.2022.830710. eCollection 2022.
4
Limited window for donation of convalescent plasma with high live-virus neutralizing antibody titers for COVID-19 immunotherapy.捐献恢复期高活病毒中和抗体滴度的血浆用于 COVID-19 免疫治疗的窗口期有限。
Commun Biol. 2021 Feb 24;4(1):267. doi: 10.1038/s42003-021-01813-y.
5
Production of anti-SARS-CoV-2 hyperimmune globulin from convalescent plasma.从恢复期血浆中生产抗 SARS-CoV-2 超免疫球蛋白。
Transfusion. 2021 Jun;61(6):1705-1709. doi: 10.1111/trf.16378. Epub 2021 Mar 22.
6
SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain.SARS-CoV-2 中和抗体对全长刺突蛋白和受体结合域的反应。
J Immunol. 2021 Aug 1;207(3):878-887. doi: 10.4049/jimmunol.2100272. Epub 2021 Jul 23.
7
Role of Immunoglobulin M and A Antibodies in the Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2.免疫球蛋白 M 和 A 抗体在中和严重急性呼吸综合征冠状病毒 2 中的作用。
J Infect Dis. 2021 Mar 29;223(6):957-970. doi: 10.1093/infdis/jiaa784.
8
Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients.COVID-19 患者症状出现后七个月内 SARS-CoV-2 特异性和中和抗体的动力学。
Microbiol Spectr. 2021 Oct 31;9(2):e0059021. doi: 10.1128/Spectrum.00590-21. Epub 2021 Sep 22.
9
A tissue culture infectious dose-derived protocol for testing of SARS-CoV-2 neutralization of serum antibodies on adherent cells.基于组织培养感染剂量的 SARS-CoV-2 中和血清抗体试验的贴壁细胞检测方法。
STAR Protoc. 2021 Dec 17;2(4):100824. doi: 10.1016/j.xpro.2021.100824. Epub 2021 Aug 27.
10
Presence and short-term persistence of SARS-CoV-2 neutralizing antibodies in COVID-19 convalescent plasma donors.COVID-19 恢复期血浆捐献者中 SARS-CoV-2 中和抗体的存在和短期持久性。
Transfusion. 2021 Apr;61(4):1148-1159. doi: 10.1111/trf.16261. Epub 2021 Jan 16.

引用本文的文献

1
Comprehensive analysis of human coronavirus antibody responses in ICU and non-ICU COVID-19 patients reveals IgG3 against SARS-CoV-2 spike protein as a key biomarker of disease severity.对ICU和非ICU新冠肺炎患者的人类冠状病毒抗体反应进行的综合分析显示,针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白的IgG3是疾病严重程度的关键生物标志物。
J Med Microbiol. 2025 May;74(5). doi: 10.1099/jmm.0.002012.
2
Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection.描述抗体介导的选择压力如何驱动 SARS-CoV-2 在持续性感染期间在宿主内进化。
PLoS Pathog. 2024 Oct 15;20(10):e1012624. doi: 10.1371/journal.ppat.1012624. eCollection 2024 Oct.
3

本文引用的文献

1
Highly active engineered IgG3 antibodies against SARS-CoV-2.针对 SARS-CoV-2 的高活性工程 IgG3 抗体。
Proc Natl Acad Sci U S A. 2021 Oct 1;118(42). doi: 10.1073/pnas.2107249118.
2
Assessment of avidity related to IgG subclasses in SARS-CoV-2 Brazilian infected patients.评估 SARS-CoV-2 巴西感染患者与 IgG 亚类相关的亲合力。
Sci Rep. 2021 Sep 3;11(1):17642. doi: 10.1038/s41598-021-95045-z.
3
Serological analysis reveals an imbalanced IgG subclass composition associated with COVID-19 disease severity.血清学分析显示,与 COVID-19 疾病严重程度相关的 IgG 亚类组成失衡。
SARS-CoV-2 Variants from Long-Term, Persistently Infected Immunocompromised Patients Have Altered Syncytia Formation, Temperature-Dependent Replication, and Serum Neutralizing Antibody Escape.
长期持续性感染免疫功能低下患者的 SARS-CoV-2 变异株具有改变的合胞体形成、温度依赖性复制和血清中和抗体逃逸。
Viruses. 2024 Sep 9;16(9):1436. doi: 10.3390/v16091436.
4
COVID-19 therapeutics.新型冠状病毒治疗药物。
Clin Microbiol Rev. 2024 Jun 13;37(2):e0011923. doi: 10.1128/cmr.00119-23. Epub 2024 May 21.
5
Altered IgG4 Antibody Response to Repeated mRNA versus Protein COVID Vaccines.与蛋白质新冠疫苗相比,重复接种mRNA新冠疫苗后IgG4抗体反应的改变。
medRxiv. 2024 Jan 18:2024.01.17.24301374. doi: 10.1101/2024.01.17.24301374.
6
The Impact of Pathogen Reduction on Total IgG and IgG Subclass Profiles of Convalescent Plasma.病原体灭活对恢复期血浆总IgG及IgG亚类谱的影响
Transfus Med Hemother. 2023 Jun 21;50(6):525-530. doi: 10.1159/000530055. eCollection 2023 Dec.
7
Atopy and Elevation of IgE, IgG3, and IgG4 May Be Risk Factors for Post COVID-19 Condition in Children and Adolescents.特应性以及IgE、IgG3和IgG4升高可能是儿童和青少年新冠后状况的危险因素。
Children (Basel). 2023 Sep 25;10(10):1598. doi: 10.3390/children10101598.
8
Complement is activated by elevated IgG3 hexameric platforms and deposits C4b onto distinct antibody domains.补体通过升高的 IgG3 六聚体平台被激活,并将 C4b 沉积到不同的抗体结构域上。
Nat Commun. 2023 Jul 7;14(1):4027. doi: 10.1038/s41467-023-39788-5.
9
Glyco engineered pentameric SARS-CoV-2 IgMs show superior activities compared to IgG1 orthologues.糖基工程五聚体 SARS-CoV-2 IgM 比 IgG1 同源物具有更高的活性。
Front Immunol. 2023 Jun 8;14:1147960. doi: 10.3389/fimmu.2023.1147960. eCollection 2023.
10
Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient.免疫功能低下患者双重单克隆抗体治疗后 SARS-CoV-2 完全逃逸。
Nat Commun. 2023 Apr 10;14(1):1999. doi: 10.1038/s41467-023-37591-w.
Cell Rep Med. 2021 Jul 20;2(7):100329. doi: 10.1016/j.xcrm.2021.100329. Epub 2021 Jun 15.
4
The Characterization of Disease Severity Associated IgG Subclasses Response in COVID-19 Patients.COVID-19 患者疾病严重程度相关 IgG 亚类反应的特征。
Front Immunol. 2021 Mar 4;12:632814. doi: 10.3389/fimmu.2021.632814. eCollection 2021.
5
Functional Antibodies in COVID-19 Convalescent Plasma.新冠康复者血浆中的功能性抗体
medRxiv. 2021 Mar 11:2021.03.08.21253157. doi: 10.1101/2021.03.08.21253157.
6
Comprehensive analysis of SARS-CoV-2 antibody dynamics in New Zealand.新西兰新冠病毒抗体动态的综合分析
Clin Transl Immunology. 2021 Mar 14;10(3):e1261. doi: 10.1002/cti2.1261. eCollection 2021.
7
Robust correlations across six SARS-CoV-2 serology assays detecting distinct antibody features.六种检测不同抗体特征的新冠病毒血清学检测方法之间存在强相关性。
Clin Transl Immunology. 2021 Feb 28;10(3):e1258. doi: 10.1002/cti2.1258. eCollection 2021.
8
Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2.IgM 在恢复期血浆对 SARS-CoV-2 的中和活性中起主要作用。
Cell Rep. 2021 Mar 2;34(9):108790. doi: 10.1016/j.celrep.2021.108790. Epub 2021 Feb 10.
9
Rapid seroconversion and persistent functional IgG antibodies in severe COVID-19 patients correlates with an IL-12p70 and IL-33 signature.在重症 COVID-19 患者中,快速的血清转换和持续存在的功能性 IgG 抗体与 IL-12p70 和 IL-33 特征相关。
Sci Rep. 2021 Feb 10;11(1):3461. doi: 10.1038/s41598-021-83019-0.
10
Sensitivity of anti-SARS-CoV-2 serological assays in a high-prevalence setting.高流行地区抗 SARS-CoV-2 血清学检测的敏感性。
Eur J Clin Microbiol Infect Dis. 2021 May;40(5):1063-1071. doi: 10.1007/s10096-021-04169-7. Epub 2021 Feb 3.